Pap Smear Screening and Determinants in Women With Type 2 Diabetes at a Public Hospital in Guanajuato
Franco Torres, D. A.; Palacios Flores, P.; Avalos, A.; Sanchez Barajas, M.
Show abstract
Cervical cancer is a leading cause of cancer-related deaths among Mexican women [75]. Women with type 2 diabetes mellitus are more prone to HPV infections, raising their cervical cancer risk [23]. Despite global guidance for Pap smear screening, coverage is low in this group [30]. This study will assess Pap smear use among women aged 21 to 64 with type 2 diabetes at the HGZC/MF No. 21 clinic in Leon, Guanajuato, in late 2024. Using random sampling and a cross-sectional design, the study will evaluate sociodemographic and clinical factors through structured interviews, aiming to identify screening coverage gaps and guide early prevention strategies for women with chronic illnesses [33].
Matching journals
The top 2 journals account for 50% of the predicted probability mass.